Editorial: Advances in stem cell therapy: new applications and innovative therapeutic approaches.
作者信息
Marcuzzi Annalisa, Maximova Natalia
机构信息
Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Department of Pediatrics, Bone Marrow Transplant Unit, Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy.
出版信息
Front Med (Lausanne). 2023 Aug 8;10:1225551. doi: 10.3389/fmed.2023.1225551. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Advances in stem cell therapy: new applications and innovative therapeutic approaches.社论：干细胞治疗的进展：新应用与创新治疗方法
Front Med (Lausanne). 2023 Aug 8;10:1225551. doi: 10.3389/fmed.2023.1225551. eCollection 2023.
2
Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on "Off-the-Shelf" T Cell Therapy Using iPSC Technology and Gene Editing.异体癌细胞治疗的进展和使用 iPSC 技术和基因编辑的“现成”T 细胞治疗的未来展望。
Cells. 2022 Jan 13;11(2):269. doi: 10.3390/cells11020269.
3
Generation of induced pluripotent stem cell (iPSC) from NY-ESO-I-specific cytotoxic T cells isolated from the melanoma patient with minor HLAs: The practical pilot study for the adoptive immunotherapy for melanoma using iPSC technology.从患有轻度人类白细胞抗原（HLA）的黑色素瘤患者中分离出的NY-ESO-I特异性细胞毒性T细胞诱导生成诱导多能干细胞（iPSC）：使用iPSC技术进行黑色素瘤过继性免疫治疗的实际初步研究。
Exp Dermatol. 2023 Feb;32(2):126-134. doi: 10.1111/exd.14686. Epub 2022 Oct 21.
4
A risk-based approach for cell line development, manufacturing and characterization of genetically engineered, induced pluripotent stem cell-derived allogeneic cell therapies.基于风险的基因工程、诱导多能干细胞衍生的同种异体细胞治疗的细胞系开发、制造和表征方法。
Cytotherapy. 2023 Jan;25(1):1-13. doi: 10.1016/j.jcyt.2022.08.001. Epub 2022 Sep 13.
5
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy.工程化诱导多能干细胞用于癌症免疫治疗。
Cancers (Basel). 2022 May 1;14(9):2266. doi: 10.3390/cancers14092266.
6
[Development of antigen-receptor modified allogeneic T cell from iPS cells for cancer immunotherapy].[用于癌症免疫治疗的源自诱导多能干细胞的抗原受体修饰同种异体T细胞的研发]
Rinsho Ketsueki. 2022;63(9):1279-1289. doi: 10.11406/rinketsu.63.1279.
7
The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture.从外周血单个核细胞培养物中生成人 γδT 细胞衍生的诱导多能干细胞。
Stem Cells Transl Med. 2018 Jan;7(1):34-44. doi: 10.1002/sctm.17-0021. Epub 2017 Nov 21.
8
Generation of Antigen-Specific T Cells from Human Induced Pluripotent Stem Cells.从人诱导多能干细胞生成抗原特异性T细胞。
Methods Mol Biol. 2019;1899:25-40. doi: 10.1007/978-1-4939-8938-6_3.
9
Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.多能成体生殖系干细胞与其他多能干细胞一样，尽管主要组织相容性复合体I类分子表达水平较低，但仍可被细胞毒性T淋巴细胞杀死。
Biol Direct. 2009 Aug 28;4:31. doi: 10.1186/1745-6150-4-31.
10
Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells.将黑色素瘤肿瘤浸润淋巴细胞重编程为诱导多能干细胞。
Stem Cells Int. 2016;2016:8394960. doi: 10.1155/2016/8394960. Epub 2015 Dec 28.
引用本文的文献
1
Combinational Therapy of Mesenchymal Stem Cells and Metformin in Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rat Model.间充质干细胞与二甲双胍联合治疗博来霉素诱导的大鼠特发性肺纤维化模型
Appl Biochem Biotechnol. 2025 Jun 21. doi: 10.1007/s12010-025-05289-y.
2
Human pancreatic islet-derived stromal cells reveal combined features of mesenchymal stromal cells and pancreatic stellate cells.人胰腺胰岛衍生基质细胞显示间充质基质细胞和胰腺星状细胞的联合特征。
Stem Cell Res Ther. 2024 Oct 8;15(1):351. doi: 10.1186/s13287-024-03963-2.
本文引用的文献
1
From bench to bedside: the history and progress of CAR T cell therapy.从实验室到临床：嵌合抗原受体 T 细胞疗法的历史与进展。
Front Immunol. 2023 May 15;14:1188049. doi: 10.3389/fimmu.2023.1188049. eCollection 2023.
2
Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force?间充质干细胞治疗神经系统疾病：原力的光明面还是黑暗面？
Front Bioeng Biotechnol. 2023 Feb 28;11:1139359. doi: 10.3389/fbioe.2023.1139359. eCollection 2023.
3
Cell and gene therapy regulatory, pricing, and reimbursement framework: With a focus on South Korea and the EU.细胞和基因治疗监管、定价和报销框架：以韩国和欧盟为例。
Front Public Health. 2023 Feb 24;11:1109873. doi: 10.3389/fpubh.2023.1109873. eCollection 2023.
4
Direct Cell Radiolabeling for Cell Tracking with PET and SPECT Imaging.直接细胞放射性标记用于正电子发射断层扫描和单光子发射计算机断层扫描的细胞示踪。
Chem Rev. 2022 Jun 8;122(11):10266-10318. doi: 10.1021/acs.chemrev.1c00767. Epub 2022 May 12.
5
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib.JAK/STAT抑制剂在儿科的新应用：芦可替尼的当前应用情况
Pharmaceuticals (Basel). 2022 Mar 19;15(3):374. doi: 10.3390/ph15030374.
6
Systematic Review and Meta-analysis of CD19-Specific CAR-T Cell Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia in the Pediatric and Young Adult Population: Safety and Efficacy Outcomes.儿童和青年复发性/难治性急性淋巴细胞白血病中 CD19 特异性嵌合抗原受体 T 细胞治疗的系统评价和荟萃分析：安全性和疗效结局。
Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):e334-e347. doi: 10.1016/j.clml.2020.12.010. Epub 2020 Dec 17.
7
Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study.iPSC 来源间充质基质细胞在急性激素耐药移植物抗宿主病中的生产、安全性和疗效：I 期、多中心、开放标签、剂量递增研究。
Nat Med. 2020 Nov;26(11):1720-1725. doi: 10.1038/s41591-020-1050-x. Epub 2020 Sep 14.
Zotero 插件